510(k) device
Rta Model D Retinal Thickness Analyzer
Talia Technology , Ltd. · Ophthalmoscope, Ac-Powered (HLI, Class II) · First FDA decision May 6, 2003, newest May 24, 2004GlaucomaMacular degeneration and retinal disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Rta"
MAUDE reports
0
Brand "Rta", since 2015
PubMed studies
3,716
Mentioning "Rta"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Rta Model D Retinal Thickness Analyzer
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K041290 · Decided May 24, 2004 · 11 days after receipt
Device type: Ophthalmoscope, Ac-Powered (HLI) · Ophthalmology
K031312 · Decided May 6, 2003 · 12 days after receipt
Device type: Ophthalmoscope, Ac-Powered (HLI) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Portable Hand-Held X-Ray InstrumentNational determinationOn the books220.10Updated Apr 20, 2020
- Fluidized Therapy Dry Heat for Certain Musculoskeletal DisordersNational determinationOn the books150.8Updated Apr 17, 2020
- Certain Drugs Distributed by the National Cancer InstituteNational determinationOn the books110.2Updated Jan 20, 2017
Clinical trials
Device studies on ClinicalTrials.gov that name "Rta", any status and sponsor, newest update first.
No registered device study names "Rta".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Rta", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code HLI
8 reports: 5 malfunction, 3 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Rta"[tiab]. The summary above synthesizes these.
- Renal Tubular Acidosis and Management Strategies: A Narrative Review.
Palmer BF, Kelepouris E, Clegg DJ · Adv Ther · 2021Research Support, Non-U.S. Gov't, Review
- A review of renal tubular acidosis.
Kunchur MG, Mauch TJ, Parkanzky M, et al. · J Vet Emerg Crit Care (San Antonio) · 2024Review
- Renal Tubular Acidosis.
Bagga A, Sinha A · Indian J Pediatr · 2020Review
- Renal tubular acidosis.
Santos F, Gil-Peña H, Alvarez-Alvarez S · Curr Opin Pediatr · 2017Review
- [Tubular renal acidosis].
Seidowsky A, Moulonguet-Doleris L, Hanslik T, et al. · Rev Med Interne · 2014Case Reports, English Abstract
- Hyperchloremic normal gap metabolic acidosis.
Palmer BF, Clegg DJ · Minerva Endocrinol · 2019Review
- Single-Domain Antibodies for Intracellular Toxin Neutralization.
Czajka TF, Mantis NJ · Methods Mol Biol · 2022Research Support, N.I.H., Extramural
- Renal tubular acidosis.
Rodríguez-Soriano J, Vallo A · Pediatr Nephrol · 1990Review
- Renal Tubular Acidosis in the Neonate.
Lee BR · Neoreviews · 2024Review, Research Support, Non-U.S. Gov't
- KSHV RTA utilizes the host E3 ubiquitin ligase complex RNF20/40 to drive lytic reactivation.
Spires LM, Wind E, Papp B, et al. · J Virol · 2023Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.
Ali A, Ohashi M, Casco A, et al. · PLoS Pathog · 2022Research Support, N.I.H., Extramural
Other devices of this type
Also filed under product code HLI.
- RTVue XR OCT Avanti with AngioVue SoftwareOptovue, Inc. · 510(k) 2016
- Stratusoct with Rnfl & Macula Normative DatabaseCarl Zeiss Meditec, Inc. · 510(k) 2004
- EnFocus 2300, EnFocus 4400Bioptigen, Inc. · 510(k) 2015
- OCT-CameraOptomedical Technologies GmbH · 510(k) 2015
- Propper Insight Binocular Indirect OphthalmosopePropper Manufacturing Co., Inc. · 510(k) 2014
- Centervue Macular Integrity AssessmentCentervue S.P.A. · 510(k) 2014
- Amico DH-W35 Ophthalmoscope SeriesAmico Diagnostic Incorporated · 510(k) 2014
- Ivue 500Optovue, Inc. · 510(k) 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.